Clone: RXB.14
Background: Anti-hCD10 recognizes a human common acute lymphoblastic antigen (CALLA), MW 100 kDa. The CD10 antigen is identical to human membraneassociated neutral endopeptidase ( NEP;EC 3.3.24.11), also known as enkephalinase. The CD10 antigen is found on lymphocytes from patients with acute B-lymphoid leukemia. The antigen is also present on a wide variety of normal and neoplastic cell types including renal epithellum, fibroblasts, granulocytes and some lymphoma, melanoma and glioma cell lines
Purification Method: Protein A/G Chromatography
Concentration: See vial for concentration
Formulation: Provided as solution in phosphate buffered saline with 0.08% sodium azide
References: 1. CD10/Neutral Endopeptidase 24.11 Hydrolyzes Bombesin-like Peptides and Regulates the Growth of Small Cell Carcinomas of the Lung. Proc Natl Acad Sci USA 1991, Dec1;88(23):10662-6. Shipp, MA, Tarr, GE; Chen, CY; Switzer, SN; Hersh, LB; Stein,H; Sunday, ME; Reinherz, EL. 2 Induction of Isotype Switching and Ig Production by CD5+ and CD10+ Human Fetal B Cells. JI, 1992, Jun1;148(11):3398-404. Punnonen, J; Aversa, GG;Vandekerckhove, B; Roncarolo, MG; de Vries, JE. 3. Murine Common Acute Lymphoblastic Leukemia Antigen (CD10 Neutral Endopeptidase 24.11). Molecular Characterization, Chromosomal Localization and Modeling of the Active Site. JI, 1992, May1;148(9):2817-25. Chen, CY; Salles, G; Seldin, MF; Kister, AE; Reinherz, EL; Shipp, MA. 4. Childhood Acute Leukemia with t(11;19) (q23;p13). SO. Leukemia, 1991, Dec;5(12):1064-8. Hudson, MM; Raimondi, SC; Behm, FG; Pui, CH. 5. CD10 (CALLA)/Neutral Endopeptidase 24.11 Modulates Inflammatory Peptide-Induced Changes in Neutrophil Morphology, Migration and Adhesion Proteins and is itself Regulated by Neutrophil Activation. Blood, 1991, Oct. 1;78(7):1834-41. Shipp, MA; Stefano, GB; Switzer, SN; Griffin, JD; Reinherz, EL. 6. Functional Properties of CD19+ B Lymphocytes Positively Selected from Buffy Coats by Immunomagnetic Separation. Funderud, S., Erikstien, B., Asheim, H.C., Nustad ,K., Stokke, T., Blomhoff, H.K., Holte, H., Smeland, E.B.. Eur. J. Immunol. 1990 Ja;20(1):201-6 7. Thymic B Cells from Myasthenia Gravis Patients are Activated B Cells. Phenotypic and Functional Analysis. Leprince, C., Cohen-Kaminsky, S., Berrih-Aknin, S., Vernet-Der Garabedian, B., Treton, D., Galanaud, P., Richard, Y., J. Immunol. 1990 Oct., 145(7):2115-22. 8. Prognostic Significance of CD34 Expression in Childhood B Precursor Acute Lymphocytic Leukemia: A Pediatric Onocology Group Study. Borowitz, M.J., Shuster, J.J., Civin, C.I., Carrol, A.J., Look, A.T., Behm, F.G., Land, V.J., Pullen, D.J., Crist, W.M.. J. Clin. Onol. 1990 Au;8(8):1389-98. 9. Biphenotypic Acute Leukemia in Adults. Sulak, L.E., Clare, C.N., Morale, B.A., Hansen, K.L., Montiel, M.M.. Am. J. Clin. Path. 1990 Ju;94(1):54-8. 10. Intersection of the Complement and Immune Systems: A Signal Transduction Complex of the B Lymphocyte Containing Complement Receptor type 2 and CD19. Matsumoto, A.K., Kopicky-Burd , J., Carter, R.H., Tuveson, D.A., Tedder, T.F., Fearon, D.T., J. Exp. Med. 1991 Jan. 173(1):55-64.
UniProt: P08473
Caution: This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals.
English
Deutsch
